Medicare Enrolled
Dr. Hollis Sigman, MD
Urology Physician · Columbus, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sigman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sigman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sigman
Dr. Hollis Sigman is an urology physician in Columbus, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sigman performed 34,895 Medicare services across 2,108 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sigman received a total of $5,957 from 57 pharmaceutical and/or device companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sigman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in GA
$5,957 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,895
Medicare services
Top 2% in GA for urology physician
2,108
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,837 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
25,950 | $0 | $1 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,750 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,025 | $83 | $370 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
966 | $2 | $9 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 270 | $134 | $771 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
171 | $18 | $97 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
133 | $10 | $69 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
105 | $160 | $652 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $107 | $561 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
74 | $7 | $59 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $56 | $253 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
44 | $42 | $271 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $24 | $126 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
39 | $75 | $407 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
37 | $135 | $850 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
32 | $253 | $1,498 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
25 | $221 | $1,323 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
18 | $8 | $23 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
16 | $56 | $262 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $97 | $468 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
13 | $254 | $1,153 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
13 | $24 | $614 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $140 | $779 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $161 | $861 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,957
Total received (2018-2024)
Avg $851/year across 7 years
Top 36% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
297
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,804 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$153 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,254
2023
$1,209
2022
$881
2021
$833
2020
$345
2019
$532
2018
$904
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$217
ABBVIE INC.
$172
Endo USA, Inc.
$116
Sumitomo Pharma America, Inc.
$113
Boston Scientific Corporation
$89
ABC Home Medical Supply, Inc.
$73
Myriad Genetic Laboratories, Inc.
$67
PFIZER INC.
$56
180 Medical, Inc.
$48
Tolmar, Inc.
$44
Axonics, Inc.
$37
Merck Sharp & Dohme LLC
$31
Endo Pharmaceuticals Inc.
$24
Medtronic, Inc.
$22
Astellas Pharma US Inc
$21
Calyxo, Inc.
$20
COLOPLAST CORP
$19
Olympus America Inc.
$18
Ferring Pharmaceuticals Inc.
$18
BIOPROTECT MEDICAL, INC.
$17
PROGENICS PHARMACEUTICALS, INC.
$16
Ambu Inc.
$16
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$921
Endo Pharmaceuticals Inc.
$532
Sumitomo Pharma America, Inc.
$438
Janssen Biotech, Inc.
$336
PROCEPT BioRobotics Corporation
$298
ABBVIE INC.
$294
AbbVie Inc.
$263
Boston Scientific Corporation
$214
180 Medical, Inc.
$196
Myriad Genetic Laboratories, Inc.
$182
TOLMAR Pharmaceuticals, Inc.
$169
Caldera Medical, Inc
$145
Dendreon Pharmaceuticals LLC
$140
AbbVie, Inc.
$128
Myovant Sciences Inc.
$120
Endo USA, Inc.
$116
UROVANT SCIENCES INC
$88
Axonics, Inc.
$86
C. R. Bard, Inc. & Subsidiaries
$76
ABC Home Medical Supply, Inc.
$73
PFIZER INC.
$73
Coloplast Corp
$70
Tolmar, Inc.
$68
Medtronic, Inc.
$67
Laborie Medical Technologies Corp.
$66
AngioDynamics, Inc.
$66
Blue Earth Diagnostics Limited
$60
Bayer HealthCare Pharmaceuticals Inc.
$53
Antares Pharma, Inc.
$46
Ambu Inc.
$39
Amgen Inc.
$36
DENTSPLY IH Inc.
$33
Travere Therapeutics, Inc.
$32
Ferring Pharmaceuticals Inc.
$31
Merck Sharp & Dohme LLC
$31
COLOPLAST CORP
$31
Medtronic USA, Inc.
$30
Allergan, Inc.
$24
Rochester Medical Corporation
$23
Teleflex LLC
$22
Calyxo, Inc.
$20
Olympus America Inc.
$18
Aytu BioScience, Inc
$18
BIOPROTECT MEDICAL, INC.
$17
UROGEN PHARMA, INC.
$17
PROGENICS PHARMACEUTICALS, INC.
$16
AstraZeneca Pharmaceuticals LP
$16
Allergan Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Cook Medical LLC
$14
SRS Medical Systems, Inc.
$13
Zyla Life Sciences
$13
AKRIMAX PHARMACEUTICALS, LLC
$12
Egalet US Inc
$11
Avadel Specialty Pharmaceuticals, LLC
$11
Wilmington Medical Supply, Inc.
$11
Retrophin, Inc.
$4
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 700 · AMS Ambicor · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · CONTINENCE CARE · CURE CATHETER · CVAC ASPIRATION SYSTEM · Desara · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENTLECATH · INLAY OPTIMA · INTERSTIM · Isiris aStent Removal Device · JELMYTO · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RESONANCE · Rezum Generator · SPEEDICATH · SPRIX · SpeediCath · Stendra · TITAN · TOVIAZ · Thiola · Titan · UROLIFT · UroCuff · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xpeeda DSL Fiber · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
10
Per 100K population
4.9
County median income
$56,622
Nearest hospital
PIEDMONT COLUMBUS REGIONAL MIDTOWN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sigman is a mixed practice specialist, with above-average Medicare volume (top 2% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sigman experienced with testosterone injection?
Based on Medicare claims data, Dr. Sigman performed 25,950 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sigman receive payments from pharmaceutical companies?
Yes. Dr. Sigman received a total of $5,957 from 57 companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sigman's costs compare to other urology physicians in Columbus?
Dr. Sigman's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sigman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Columbus
Browse urology physicians in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology